EnLyte to Be Presented at the Medical Academy of Pediatric Special Needs Conference in Orlando, September 11-13
PR Web |
Families of children with these needs are increasingly seeking alternative treatment options. In fact, in a new study published in the
EnLyte with Delta Folate is an advanced generation prescription folate therapy designed to address common genetic polymorphisms such as the MTHFR defect, and to lower elevated homocysteine-two factors common in ASD. According to Dr.
Factors like diet restrictions, absorption issues, and genetic factors-most notably the MTHFR defect-are unique and significant to Autism, being major players in decreasing the body's ability to absorb B vitamins.
"It's been my experience over the last 16 years that I've been in the Autism community that parents are experimenting with alternative treatments for their children. It's nice to finally find a nutritional supplement regulated by the
About EnLyte
EnLyte Is the first and only prescription folate therapy containing L-Methylfolate Magnesium, Folinic Acid, and Folic Acid, and all the necessary B-vitamin metabolites, in optimal doses, to completely address the remethylation and transsulfuration cycles, address genetic polymorphisms, and reduce high homocysteine. It is gluten free, casein free, dye free, and preservative free.
About JayMac
Learn more at http://www.EnLyteRx.Com
Read the full story at http://www.prweb.com/releases/2014/09/prweb12150194.htm
Copyright: | (c) 2014 PRWEB.COM Newswire |
Wordcount: | 467 |
National Safety Council Announces 2014 Class of NSC Rising Stars of Safety
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News